Xeris Pharmaceuticals Financial Overview
Xeris Pharmaceuticals's market cap is currently $1.16B. The company's EPS TTM is $0; its P/E ratio is -67.79; Xeris Pharmaceuticals is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
